Liraglutide
The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes
Novo Nordisk · Phase 2 · Completed · Enrollment 564
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Lira placebo/Lira 2.4 mg/Lira 3.0 mg | Obesity or overweight | 3.0 mg | n/r | n/r | n/r |
| Lira 1.2 mg/Lira 3.0 mg | Obesity or overweight | 3.0 mg | n/r | n/r | n/r |
| Lira 1.8 mg/Lira 3.0 mg | Obesity or overweight | 3.0 mg | n/r | n/r | n/r |
| Lira 2.4 mg/Lira 3.0 mg | Obesity or overweight | 3.0 mg | n/r | n/r | n/r |
| Liraglutide 3.0 mg | Obesity or overweight | 3.0 mg | n/r | n/r | n/r |
| Orlistat | Obesity or overweight | n/r | n/r | n/r | n/r |